• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.62 0.01(0.81%) Jan 29, 4:00PM EST
    Add to Portfolio
    Prev Close:0.62
    Open:0.65
    Bid:0.56 x 1000
    Ask:1.46 x 2000
    1y Target Est:1.45
    Beta:0.51
    Earnings Date:Mar 30 - Apr 3 (Est.)
    Day's Range:0.62 - 0.65
    52wk Range:0.53 - 1.38
    Volume:91,370
    Avg Vol (3m):130,027
    Market Cap:31.75M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYDown 0.81%31.75M
    ABT68.15B
    PFE200.55B
    SNN16.23B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.30
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing product candidates for the therapeutic needs of anti-infective market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback